Dr. Chamie is an Associate Professor of Urology at UCLA and Director of Fellowship and the Bladder Cancer Program at the UCLA Institute of Urologic Oncology. He attended Medical School at USC and completed Urological training at UC Davis. Dr. Chamie then completed a SUO certified fellowship in Urologic Oncology at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on bladder cancer and robotic surgery.
Wayne Brisbane, MD
Fellow, Institute of Urologic Oncology
Dr. Brisbane obtained his medical degree from Loma Linda University School of Medicine in California. He completed a residency in Urology at the University of Washington. His research at the University of Washington included work at the Center for Industrial and Medical Ultrasound where he studied novel ablative therapy for kidney cancer using focused ultrasound. Starting in July of 2019 Dr. Brisbane began a two-year fellowship in Urologic Oncology at UCLA. Dr. Brisbane's current research evaluates novel imaging modalities for the diagnosis of prostate cancer. He is also involved in research on robotic surgery of the prostate.
Katherine Fero, MD
Resident, UCLA Department of Urology (PGY-4)
Dr. Kelly Fero was born in San Francisco and raised in the Bay Area. She studied Biology at Stanford University and performed honors thesis research in Molecular and Cellular Biology. At Stanford she was a member of the NCAA Division 1 Women’s Rowing Team. She attended UC San Diego School of Medicine where she was awarded an NIH training grant that funded a dedicated research year and Masters degree program. Her masters studies were focused in biostatistics and her area of research interest at UCSD was practice variability and cost-effectiveness of oncologic surgical interventions. She will spend her research year with Dr Karim Chamie and the support of an AUA Care Grant, developing a validated symptoms questionnaire for patients undergoing intravesical therapy for bladder cancer. In her free time Kelly enjoys surfing, skiing and distance running. She looks forward to a career in academic urology.
Patrick Lec, MD
Resident, UCLA Department of Urology (PGY-5)
Dr. Patrick Lec grew up between Orono, ME, Philadelphia, PA, and Krakow, Poland. He completed both his undergraduate studies in Human Biology and his medical education at Brown University as a student in the Program in Liberal Medical Education. Patrick is currently finishing a research year under the mentorship of Dr Karim Chamie, investigating intravesical checkpoint inhibition in non-muscle invasive bladder cancer, the role of opioid receptors in urothelial carcinoma, and the quality of care delivered to patients with bladder or upper tract urothelial cancer. He plans to pursue a fellowship and academic career in urologic oncology.
Dr. Patel received his medical degree from George Washington University and subsequently completed his residency in Urology at New York Presbyterian Hospital-Weill Cornell Medicine. He now joins the Institute of Urologic Oncology at UCLA to complete a two-year SUO fellowship in Urologic Oncology. His clinical and research focus are in managing kidney cancer and improving pre-treatment risk stratification of renal masses.
